HOME >> BIOLOGY >> NEWS
Female guppies risk their lives to avoid too much male attention

Sexual harassment is a burden that females of many species face, and some may go to extreme lengths to avoid it. In a new paper from the June issue of the American Naturalist, Darren Croft (University of Wales) and a research team from the University of Leeds suggest that female guppies, a popular aquarium fish, may risk their lives to avoid too much attention from males. Observing wild population of guppies in the rainforest of Trinidad, the researchers found that female guppies swim in habitats that contain few males but many predators.

"Male guppies spend most of their time displaying to females. But if their courtship displays don't impress the females, males will attempt to sneak mating with them when they aren't looking," says Croft.

Male guppies are brightly colored to attract female attention, while female guppies are a dull brown color. The researchers show that female guppies might use this color difference to their advantage, venturing into the deep water where predators lurk. The males' bright coloring also attracts predators, making it too dangerous for them to follow.

"Understanding why and how [sexual segregation] occurs is essential if we are going to conserve and protect species and habitats," explains Croft, who points out that fish are not the only species who display this social characteristic. "In many ecosystems, predators are the first to go extinct, and our work shows that this may have many, perhaps unexpected, effects. In this case, females may suffer more sexual harassment."


'"/>

Contact: Suzanne Wu
swu@press.uchicago.edu
773-834-0386
University of Chicago Press Journals
12-May-2006


Page: 1

Related biology news :

1. Female gender provides an advantage in renal diseases
2. Females more prone to brain damage from alcohol abuse
3. Female iguanas pay high costs to choose a mate
4. Female-led infanticide in wild chimpanzees
5. Female ticks have market on gluttony
6. Females do best if they wait a while
7. Female chimps keep the bullies at bay
8. Female Antarctic seals give cold shoulder to local males
9. Female pronghorns choose mate based on substance as well as show
10. Female birds boost up their eggs when hearing sexy song
11. Females, alcohol and hormones

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Female guppies risk their lives avoid too much male attention

(Date:12/10/2014)... 08, 2014 Research and Markets ... the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of ... rural banking and upgradation of the driver,s license ... the market. Besides the aforementioned projects, biometrics is ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
(Date:12/4/2014)... 3, 2014  Crossmatch™, a leading provider of ... DigitalPersona ® Pro Enterprise software and U.are.U ... throughout First Bank branch locations in ... and Virginia. First Bank, a progressive community ... North Carolina , selected the Crossmatch biometrics-based ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... 17, 2014 Audacity, a leading California-based ... member of the Huntsworth Health Group, is proud to ... team. In her role, Gonzales will serve as Senior ... incredibly honored to welcome a talent of Jamie’s caliber ... Gaëtan Fraikin. “She is a proven healthcare innovation leader ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: